Serina Therapeutics Announces Dr. William K. Schmidt will Join the Clinical Advisory Board.

By |October 28th, 2019|News|0 Comments

Serina Therapeutics Publishes Invited Manuscript on Tuning Drug Delivery

By |October 14th, 2019|News|0 Comments

Serina Therapeutics Receives NIH Grant to Develop SER-227 for Post-Operative Pain

By |September 30th, 2019|News|0 Comments

Serina Announces CEO Will Present at Neurotech Investing and Partnership 2019

By |May 21st, 2019|News|0 Comments

Serina Announces CEO Will Present at BIO CEO and Investor 2019

By |February 8th, 2019|News|0 Comments

Serina Announces CEO Will Present Keynote Lectures at Major Conferences in 2019

By |December 3rd, 2018|News|0 Comments

The Next Generation in Polymer Therapeutics, Neurotech Investing and Partnership Conference

By |May 1st, 2018|News|0 Comments

Serina Therapeutics Retains Evolution Venture Partners for Follow-on Financing of $ 30 M

By |June 27th, 2017|News|0 Comments

Serina Therapeutics Announces Completion of Enrollment in the Phase Ia Trial of SER-214 in Parkinson’s Disease

By |February 14th, 2017|News|0 Comments

Serina Therapeutics Announces Appointment of Mr. Mike Loya to Serina’s Board of Directors

By |January 26th, 2017|News|0 Comments